AU2001268422A1 - Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders - Google Patents
Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disordersInfo
- Publication number
- AU2001268422A1 AU2001268422A1 AU2001268422A AU6842201A AU2001268422A1 AU 2001268422 A1 AU2001268422 A1 AU 2001268422A1 AU 2001268422 A AU2001268422 A AU 2001268422A AU 6842201 A AU6842201 A AU 6842201A AU 2001268422 A1 AU2001268422 A1 AU 2001268422A1
- Authority
- AU
- Australia
- Prior art keywords
- agmatine
- seizure
- epilepsy
- treatment
- analogs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- QYPPJABKJHAVHS-UHFFFAOYSA-P agmatinium(2+) Chemical compound NC(=[NH2+])NCCCC[NH3+] QYPPJABKJHAVHS-UHFFFAOYSA-P 0.000 title 2
- QYPPJABKJHAVHS-UHFFFAOYSA-N Agmatine Natural products NCCCCNC(N)=N QYPPJABKJHAVHS-UHFFFAOYSA-N 0.000 title 1
- 206010010904 Convulsion Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 206010015037 epilepsy Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21153200P | 2000-06-15 | 2000-06-15 | |
US60211532 | 2000-06-15 | ||
PCT/US2001/019095 WO2001095897A1 (fr) | 2000-06-15 | 2001-06-15 | Agmatine et analogues d'agmatine dans le traitement de l'epilepsie, de la febrilite et de troubles electroconvulsifs |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001268422A1 true AU2001268422A1 (en) | 2001-12-24 |
Family
ID=22787315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001268422A Abandoned AU2001268422A1 (en) | 2000-06-15 | 2001-06-15 | Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders |
Country Status (3)
Country | Link |
---|---|
US (1) | US7816407B2 (fr) |
AU (1) | AU2001268422A1 (fr) |
WO (1) | WO2001095897A1 (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060111743A1 (en) * | 2004-11-19 | 2006-05-25 | Gurney Harry C Jr | Method for arresting seizure activity |
US10435356B1 (en) | 2007-09-18 | 2019-10-08 | Thermolife International, Llc | Amino acid compositions |
US10426792B1 (en) | 2007-09-18 | 2019-10-01 | Thermolife International, Llc | Amino acid compositions |
US10646508B1 (en) * | 2007-09-18 | 2020-05-12 | Thermolife International, Llc | Method of safely administering nitrate dietary supplements and compositions |
US8466187B2 (en) | 2007-09-18 | 2013-06-18 | Thermolife International, Llc | Amino acid compositions |
US10426750B1 (en) | 2007-09-18 | 2019-10-01 | Thermolife International, Llc | Amino acid supplement formulations |
US8916612B2 (en) * | 2008-09-11 | 2014-12-23 | Gad Gilad | Agmatine containing dietary supplements, nutraceuticals, and foods |
WO2010030470A1 (fr) * | 2008-09-11 | 2010-03-18 | Gilad Gad M | Suppléments diététiques, nutraceutiques et aliments contenant de l'agmatine |
HUE032165T2 (en) | 2011-04-13 | 2017-09-28 | Thermolife Int Llc | Methods of using N-actyl-beta-alanine |
KR101497932B1 (ko) | 2013-05-08 | 2015-03-03 | 건국대학교 산학협력단 | 아그마틴 또는 이의 약학적으로 허용되는 염을 함유하는 자폐 범주성 장애 예방 또는 치료용 조성물 |
US20150182479A1 (en) * | 2013-12-30 | 2015-07-02 | Topaz Ventures, Inc. | Method of delivering agmatine for medical treatment |
TW201620887A (zh) | 2014-01-10 | 2016-06-16 | 葛蘭素史克智慧財產(第二)有限公司 | 化合物及方法 |
RU2548758C1 (ru) * | 2014-06-17 | 2015-04-20 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский институт акушерства и педиатрии" Министерства здравоохранения Российской Федерации | Способ прогнозирования возникновения судорожного синдрома у детей с перинатальными поражениями цнс в раннем неонатальном периоде |
US9993447B2 (en) | 2015-09-14 | 2018-06-12 | JW Nutritional, LLC | Systems and methods for increasing agmatine cellular uptake by oral administration |
KR20190121569A (ko) * | 2018-04-18 | 2019-10-28 | 건국대학교 글로컬산학협력단 | 아그마틴 및 이의 약학적으로 허용 가능한 염을 포함하는 취약 x 증후군 예방 또는 치료용 약학조성물 |
WO2021048871A1 (fr) | 2019-09-15 | 2021-03-18 | Celagenex Research (India) Pvt. Ltd. | Compositions bioactives synergiques pour traiter des troubles neurologiques |
US11865139B2 (en) | 2020-11-12 | 2024-01-09 | Thermolife International, Llc | Method of treating migraines and headaches |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4267374A (en) | 1977-07-01 | 1981-05-12 | Merrell Toraude Et Compagnie | Derivatives of amines and amino acids |
US4139563A (en) | 1977-07-01 | 1979-02-13 | Merrell Toraude Et Compagnie | α-ACETYLENIC DERIVATIVES OF AMINES |
US4134918A (en) * | 1977-09-06 | 1979-01-16 | Merrell Toraude Et Compagnie | Alpha-halomethyl derivatives of amines |
US4323704A (en) | 1979-06-25 | 1982-04-06 | Merrell Toraude Et Compagnie | αAcetylene and α-vinyl derivatives of amino acids |
US5242947A (en) * | 1988-02-10 | 1993-09-07 | New York University | Use of polyamines as ionic-channel regulating agents |
US5633230A (en) | 1990-10-24 | 1997-05-27 | Allelix Biopharmaceuticals, Inc. | Treatment of cytomegalovirus infection |
US5677349A (en) * | 1995-04-27 | 1997-10-14 | Gilad; Gad M. | Agmatine for the treatment of neurotrauma and neurodegenerative diseases |
FR2753098B1 (fr) * | 1996-09-06 | 1998-11-27 | Sod Conseils Rech Applic | Composition pharmaceutique comprenant au moins un inhibiteur de no synthase et au moins un piegeur des formes reactives de l'oxygene |
DE69827149T2 (de) * | 1997-08-15 | 2006-03-09 | Fairbanks, Carolyn Ann, Rochester | Agmatin für die behandlung neuropathischer schmerzen |
US6441156B1 (en) * | 1998-12-30 | 2002-08-27 | The United States Of America As Represented By The Department Of Health And Human Services | Calcium channel compositions and methods of use thereof |
-
2001
- 2001-06-15 WO PCT/US2001/019095 patent/WO2001095897A1/fr active Application Filing
- 2001-06-15 AU AU2001268422A patent/AU2001268422A1/en not_active Abandoned
- 2001-06-15 US US09/881,215 patent/US7816407B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20020065323A1 (en) | 2002-05-30 |
WO2001095897A1 (fr) | 2001-12-20 |
US7816407B2 (en) | 2010-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001268422A1 (en) | Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders | |
AU2002361811A8 (en) | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders | |
HK1091813A1 (en) | 2,4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders | |
HUP0401023A3 (en) | Use of flibanserin in the treatment of sexual disorders | |
HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
HK1051690A1 (en) | Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain. | |
EP1448205A4 (fr) | Combinaisons permettant le traitement des troubles inflammatoires | |
AU9527001A (en) | Treatment of T cell disorders | |
ZA200307475B (en) | Carbamate compounds for use in the treatment of pain. | |
EP1581206A4 (fr) | Traitement de troubles inflammatoires par des 2,3-benzodiazepines | |
GB0108671D0 (en) | Skin treatment | |
GB0213869D0 (en) | The treatment of pain | |
WO2003050137A3 (fr) | Mutations de recepteur de type toll 4 | |
EP1422743A4 (fr) | Systeme de traitement | |
IL164887A0 (en) | Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith | |
GB0127384D0 (en) | Well treatment system | |
AU2003255843A1 (en) | 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain | |
GB0105899D0 (en) | Fibrosis reduction treatment | |
AU2003293500A1 (en) | Lactoferrin in the reduction of pain | |
IL164901A0 (en) | Optically active beta-aminoketones, optically active 1,3-aminoalcohols and processes for preparing them | |
AU2002328383A1 (en) | Equipment for treating painful points in the organism | |
AU2002358267A1 (en) | Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 | |
AU2002357691A1 (en) | Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145 | |
GB0211297D0 (en) | Pain treatment | |
GB0115489D0 (en) | Pain treatment |